Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates?

doi:10.3748/wjg.v21.i29.8888

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7271)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

366

WORD

276

HTML

3504

Figures (1-2)

286

Tables (1-3)

269

Sum=4701

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

990

Download

1580

Sum=2570

Aug 7, 2015 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Aug 7, 2015; 21(29): 8888-8893
Published online Aug 7, 2015. doi: 10.3748/wjg.v21.i29.8888

Table 1 Patient characteristics (n = 95)

Variables	Value
Sex, male/female	76/19
Age (yr): median (range)	68 (37-82)
ECOG-PS: 0/1/2	62/28/5
Etiology HBV/HCV/Others	72/12/11
Child-Pugh: A/B/C	49/42/4
Maximum tumor diameter (mm): median (range)	30.0 (10.0-160.0)
Tumor distribution: unilateral/bilateral	22/73
Portal vein tumor thrombosis: yes/no	19/76
AFP (ng/mL), median (range)	86.0 (1.9-5856.0)
DCP (mAU/mL), median (range)	117 (0-204030)
Previous treatment
Surgical resection	4
PEI	25
RFA	8
TACE	34
None	24

ECOG-PS: Eastern Cooperative Oncology Group-performance status; HBV: Hepatitis B virus; HCV: Hepatitis C virus; AFP: Alpha-fetoprotein; DCP: Des-γ-carboxy prothrombin; PEI: Percutaneous ethanol injection; RFA: Radiofrequency ablation; TACE: Transcatheter arterial chemoembolization.

Citation: Suzuki E, Chiba T, Ooka Y, Ogasawara S, Tawada A, Motoyama T, Kanogawa N, Saito T, Yoshikawa M, Yokosuka O. Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates? World J Gastroenterol 2015; 21(29): 8888-8893
URL: https://www.wjgnet.com/1007-9327/full/v21/i29/8888.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i29.8888